Active Pharmaceutical Ingredients
Progestogen and Estrogen | |||
Product Name | Specification | Approved | CAS No. |
Progesterone | CP/EP/USP | CEP/EU-GMP/FDA | 57-83-0 |
Pregnenolone |
In-house |
Kosher | 145-13-1 |
Medroxyprogesterone Acetate | CP/EP/USP | DMF/GMP | 71-58-9 |
Megestrol Acetate | CP/EP/USP | DMF in process | 595-33-5 |
Mifepristone | CP/IP | DMF/GMP | 84371-65-3 |
Cyproterone Acetate | CP/EP | CEP/TGA/GMP | 427-51-0 |
Levonorgestrel | CP/EP/USP | DMF/GMP/CEP | 797-63-7 |
Drospirenone | EP/USP | DMF | 67392-87-4 |
Gestodene | CP/EP | DMF/GMP | 60282-87-3 |
Estradiol | CP/EP/USP | DMF | 50-28-2 |
Estriol | CP/EP/USP | Under R&D | 50-27- 1 |
Ethinyl Estradiol | CP/EP/USP | DMF/GMP | 57-63-6 |
Estradiol Valerate | CP | DMF in process | 979-32-8 |
Tibolone | CP/EP | DMF | 5630-53-5 |
Dienogest | EP | DMF | 65928-58-7 |
Fulvestrant | In-house | Under R&D | 129453-61-8 |
Exemestane | EP/USP | Under R&D | 107868-30-4 |
Androgen | |||
Product Name | Specification | Approved | CAS No. |
Finasteride | CP/EP/USP | CEP/FDA/PMDA/GMP | 98319-26-7 |
Dutasteride | EP/USP | CEP/DMF | 164656-23-9 |
Abiraterone Acetate | CP/USP | DMF/WC | 154229-18-2 |
Testosterone | CP/EP/USP | CEP/DMF/WC | 58-22-0 |
Testosterone Undecanoate | CP | Under R&D | 5949-44-0 |
Testosterone Cypionate | USP | Under R&D | 58-20-8 |
DHEA(Prasterone) | FP/In-house | DMF/WC/Kosher | 53-43-0 |
Clascoterone | In-house | Under R&D | 19608-29-8 |
Cortical Hormone | |||
Product Name | Specification | Approved | CAS No. |
Budesonide | CP/EP/USP | CEP/FDA/GMP | 51333-22-3 |
Desonide | USP | DMF | 638-94-8 |
Eplerenone | EP | CEP/FDA | 107724-20-9 |
Methylprednisolone | CP/EP/USP | DMF/WC | 83-43-2 |
Methylprednisolone Hemisuccinate | CP/EP/USP | DMF/WC | 2921-57-5 |
Fluticasone Propionate | CP/EP/USP | DMF | 80474- 14-2 |
Fluticasone Furoate | In-house | Under R&D | 397864-44-7 |
Others | |||
Product Name | Specification | Approved | CAS No. |
Oxcarbazepine | CP/EP/USP | CEP/USDMF | 28721-07-5 |
Eslicarbazepine Acetate | In-house | DMF in process | 236395- 14-5 |
Ganciclovir | CP/EP/USP | DMF/GMP | 82410-32-0 |
Valganciclovir Hydrochloride | USP | DMF in process | 175865-59-5 |
Oseltamivir Phosphate | CP/EP/USP | DMF | 204255- 11-8 |
Baloxavir Marboxil | In-house | Under R&D | 1985606-14-1 |
Nintedanib Esylate | In-house | DMF | 656247-18-6 |
Revefenacin | In-house | DMF in process | 864750-70-9 |
Mirabegron | In-house | DMF | 223673-61-8 |
Escitalopram Oxalate | EP/USP/CP | DMF in process | 219861-08-2 |
Cariprazine Hydrochloride | In-house | DMF in process | 1083076-69-0 |
Lasmiditan Succinate | In-house | DMF in process | 439239-92-6 |
Luliconazole | In-house | DMF | 187164-19-8 |
Apalutamide | In-house | Under R&D | 956104-40-8 |
Tadalafil | EP/USP/CP | Under R&D | 171596-29-5 |
Relugolix | In-house | Under R&D | 737789-87-6 |
Phloroglucinol | CP | DMF | 108-73-6 |
Ursodeoxycholic Acid | EP/USP/JP | Under R&D | 128-13-2 |
Main Intermediates
Product Name | Specification |
Approved |
CAS No. |
DHEA(Prasterone) | Min99.0% | DMF/WC | 53-43-0 |
DHEA Acetate(Prasterone Acetate) | Min99.0% | DMF | 853-23-6 |
Epiandrosterone | Min99.0% | TP | 481-29-8 |
16-DPA | Min99.0% | TP | 979-02-2 |
Pregnenolone acetate | Min98.0% | TP/ Kosher | 1778-02-5 |
Pregnenolone | Min99.0% | TP/Kosher | 145-13-1 |
16α-Hydroxyprednisolone | Min99.0% | DMF | 13951-70-7 |
Estrone | USP36 | TP | 53-16-7 |
Flumethasone | Min98.0% | TP | 2135-17-3 |